Compound Detail
CHEMBL2142592
TALADEGIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1
Basic Information
| ChEMBL ID | CHEMBL2142592 |
| Name | TALADEGIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | SZBGQDXLNMELTB-UHFFFAOYSA-N |
5
Targets
9
Activities
1
Assay Types
0
PK Parameters
18
Publications
3
Known Names
5
Indications
1
Mechanisms
Molecular Properties
512.5
MW (Da)
4.93
ALogP
6
HBA
0
HBD
67.2
PSA (Ų)
0.36
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Smoothened homolog antagonist | ANTAGONIST | Protein smoothened | ✓ | ✓ |
Indications
Idiopathic Pulmonary Fibrosis Neoplasms Neoplasms Neoplasm Metastasis Small Cell Lung Carcinoma
Activity Summary
IC50 9 meas. best 8.93
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Protein smoothened CHEMBL6080 | IC50 | 8.93 | 8.775 | 1.2 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.65 | 8.425 | 2.3 | 2 |
| Protein smoothened CHEMBL5971 | IC50 | 8.38 | 7.39 | 4.2 | 2 |
| Medulloblastoma cell CHEMBL4296520 | IC50 | 7.36 | 7.36 | 43.5 | 1 |
| Daoy CHEMBL612519 | IC50 | 6.1 | 6.1 | 790.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 28688278 | 10.1016/j.ejmech.2017.06.031 | Medulloblastoma cell | 2 |
| 29739714 | 10.1016/j.bmc.2018.04.058 | Unchecked | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 36270113 | 10.1016/j.bmc.2022.117051 | Unchecked | 1 |
| 28688278 | 10.1016/j.ejmech.2017.06.031 | Unchecked | 1 |
| 36270113 | 10.1016/j.bmc.2022.117051 | Mitogen-activated protein kinase 1 | 1 |
| 36270113 | 10.1016/j.bmc.2022.117051 | Protein smoothened | 1 |
| 33636537 | 10.1016/j.ejmech.2021.113268 | Daoy | 1 |
| 33636537 | 10.1016/j.ejmech.2021.113268 | Protein smoothened | 1 |
| 32063403 | 10.1016/j.bmc.2020.115354 | A2058 | 1 |
| 32063403 | 10.1016/j.bmc.2020.115354 | Daoy | 1 |
| 32063403 | 10.1016/j.bmc.2020.115354 | Protein smoothened | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 30108845 | 10.1039/C7MD00104E | Protein smoothened | 1 |
| 30108845 | 10.1039/C7MD00104E | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine